Test Price
2,800 AED✅ Home Collection Available
CSRP3 Gene Dilated Cardiomyopathy Type 1M Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين CSRP3 لاعتلال عضلة القلب التوسعي من النوع 1M في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
Diagnostic Precision: 99.9% analytical sensitivity and specificity via ISO 9001:2015-accredited NGS laboratory, ensuring clinically actionable results for cardiovascular genetic risk assessment.
Premium Logistics: Hospital-grade home collection by DHA-licensed phlebotomists between 8 AM and 11 PM, using ISO-certified cold-chain transport for DNA preservation from whole blood, FTA card, or extracted DNA.
Clinical Guidance: Telephonic post-test consultation with a cardiologist or genetic counsellor to interpret the report and integrate findings into your cardiovascular care plan.
Insurance & Billing: Direct insurance verification and pre‑approval support via WhatsApp at +971 54 548 8731. We partner with all major UAE networks.
الملخص التنفيذي: اختبار جيني دقيق بنسبة 99.9% باستخدام تقنية التسلسل الجيني من الجيل التالي، مع خدمة سحب منزلية متميزة، ودعم استشاري بعد النتيجة، وتغطية تأمينية معتمدة وفقاً لتشريعات دولة الإمارات العربية المتحدة.
Comprehensive Overview
This test analyses the CSRP3 gene via Next-Generation Sequencing (NGS) to identify pathogenic variants associated with dilated cardiomyopathy type 1M, a heritable heart muscle disease that can lead to heart failure and arrhythmias. يفحص هذا التحليل جين CSRP3 باستخدام تقنية التسلسل الجيني المتقدم لتحديد الطفرات المسببة لاعتلال عضلة القلب التوسعي الوراثي، مما يساعد في التشخيص المبكر وتقييم المخاطر العائلية.
| Feature | Our Test (NGS) | Traditional Sanger Sequencing |
|---|---|---|
| Analytical Sensitivity | >99.9% for single nucleotide variants and indels in CSRP3 | ~99% for targeted regions, may miss large deletions/duplications |
| Turnaround Time | 3–4 weeks | 6–8 weeks (gene-by-gene analysis) |
| Clinical Utility | Simultaneous coverage of all coding exons and splice sites; suitable for familial cascade testing | Limited to predefined amplicons; often requires sequential testing |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY, DHA Lic. 61713011: “A positive CSRP3 mutation result does not stand alone; it must be correlated with echocardiography, ECG, and family history. This test empowers families to make informed decisions about surveillance and early intervention, but it is not a substitute for regular cardiology follow‑up.”
‼ Medication Safety Notice
Do not discontinue or adjust any prescribed heart failure or anti‑arrhythmic medication without consulting your treating cardiologist. This genetic test provides risk information; it does not replace pharmacologic management.
Exclusion Criteria & Emergency Red Flags
- Exclusions: This test is not indicated for acute myocarditis diagnosis or in patients with decompensated heart failure requiring critical care. It cannot be performed on children below the age of consent without court‑approved guardian authorization in line with UAE CDS Law 2026.
- Emergency Red Flags: If you experience sudden chest pain, syncope (fainting), severe shortness of breath, or palpitations, seek immediate medical attention at the nearest emergency department. Do not wait for genetic test results.
- Pre‑Test Requirement: A genetic counselling session is mandatory before sample collection to document a three‑generation pedigree and obtain informed consent, in accordance with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87) and PDPL data privacy standards.
Frequently Asked Questions
1. What does the CSRP3 genetic test diagnose? / ماذا يشخص اختبار جين CSRP3 الجيني؟
The test identifies pathogenic variants in the CSRP3 gene that cause dilated cardiomyopathy type 1M, an inherited condition weakening the heart muscle. يكشف التحليل عن الطفرات المسببة لاعتلال عضلة القلب التوسعي الوراثي من النوع 1M، مما يسمح بتأكيد التشخيص وفحص أفراد العائلة.
2. How long do results take and what sample is required? / كم يستغرق ظهور النتائج وما هي العينة المطلوبة؟
Results are available within 3–4 weeks from a single blood draw, FTA card, or previously extracted DNA collected at home. تستغرق النتائج من 3 إلى 4 أسابيع بعد سحب عينة الدم أو بطاقة FTA بواسطة فريق التمريض المنزلي المعتمد.
3. Will my health insurance cover this? / هل يغطي التأمين الصحي تكلفة هذا الفحص؟
Many UAE insurers cover genetic testing for cardiomyopathy when medically indicated; our team verifies coverage and obtains pre‑approval before your appointment. تغطي معظم شركات التأمين في الإمارات الفحوصات الجينية لاعتلال عضلة القلب عند وجود ضرورة طبية، ونقوم بالتحقق من التغطية قبل الموعد لضمان تجربة سلسة.
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | DHA Facility License: 9834453 | UAE Federal Decree‑Law No. 41 of 2024 Compliant
WhatsApp Support: +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians